MW：404.42
溶解性（RT：25℃）：DMSO >81 mg/mL, Ethanol >3 mg/mL; Water <1 mg/mL
描述:
VX-702 is a second-generation, orally active p38 MAP kinase inhibitor, developed for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular diseases.[1]
参考文献 :
[1] Current Opinion in Investigational Drugs2006; 7 (11): 1020-1025
警告：
本产品仅用于科学研究，不得用于人类实验，请遵守相关规定！
欲了解更多详情，请登录：
http://www.meditechbs.com/